|
|
| | PRI-724 Basic information |
| Product Name: | PRI-724 | | Synonyms: | PRI-724;C-82,C82;(6S,9S)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl) hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide;2H-Pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide, hexahydro-6-[(4-hydroxyphenyl)methyl]-2,9-dimethyl-4,7-dioxo-N-(phenylmethyl)-8-(8-quinolinylmethyl)-, (6S,9S)-;(6S,9S)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide | | CAS: | 1198780-43-6 | | MF: | C33H34N6O4 | | MW: | 578.66 | | EINECS: | | | Product Categories: | | | Mol File: | 1198780-43-6.mol |  |
| | PRI-724 Chemical Properties |
| density | 1.39±0.1 g/cm3(Predicted) | | pka | 9.88±0.15(Predicted) |
| | PRI-724 Usage And Synthesis |
| Uses | PRI 724 is a studied as a prospect for safely and effectively targeting catenin coactivator antagonism interactions to eliminate cancer stem cell population in human cancer. |
| | PRI-724 Preparation Products And Raw materials |
|